What are the main considerations when prescribing pharmacotherapy for Parkinson’s disease?
Thomas Müller
Abstract
KEYWORDS: Parkinson's diseaseL-dopadopamine substitutionnon motor symptomsmotor symptomsdrug labelsguidelinesinnovationcureevidence-based medicine
Topics & Concepts
MedicineParkinson's diseasePharmacotherapyDiseaseIntensive care medicinePsychiatryInternal medicineParkinson's Disease Mechanisms and TreatmentsAttention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research